Search results
Showing 16 to 17 of 17 results for axicabtagene ciloleucel
Ground-breaking CAR-T therapy to treat aggressive form of blood cancer approved
More than 400 people set to benefit after NICE recommends first personalised immunotherapy for lymphoma.
NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer.